IP Library Granted Patent US 12,121,731
Granted Patent B2
US 12,121,731 · App. 17/372,487 · Granted Oct 22, 2024

Apparatus and methods for optimizing intra cardiac filling pressures, heart rate, and cardiac output

Inventors: Daniel Walter Kaiser (Nashville, TN); Clayton Allen Kaiser (Nashville, TN)
Assignee: Cardioflow Technologies, LLC
A61N1/3627A61M60/135A61M60/148A61M60/295A61M60/414A61M60/497A61M60/531A61M60/841A61N1/36521A61N1/36564A61M25/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,121,731
App. No.
17/372,487
Granted
Oct 22, 2024
Kind
B2
Abstract

Apparatus, systems, and methods are provided for optimizing intracardiac filling pressures and cardiac output in patients with heart failure, conduction disease, and atrial fibrillation. The system is able to adjust and optimize intracardiac filling pressures and cardiac output by adjusting heart rate and the effective amount of total body blood volume. The device includes an adjustable member that may create a mean pressure differential in order to manifest an effective “mechanical diuresis” by sequestering extraneous blood volume to the high-capacitance of the venous vasculature. The system is therefore designed to reduce intracardiac filling pressures while maintaining or even increasing cardiac output.

Claims (45)

1. A method for treating a patient with heart failure, comprising:

providing at least one sensor to provide sensor data corresponding to pressures within a right side of the patient's heart affected by heart failure;

introducing a distal end of an elongate member into a venous side of the patient's body, the distal end carrying an adjustable component;

manipulating the elongate member to position the adjustable component within the patient's superior vena cava; and

providing a controller coupled to the at least one sensor and the adjustable component, the controller programmed to selectively expand and collapse the adjustable component intermittently within the superior vena cava based at least in part on sensor data from the at least one sensor to occlude blood flow within the superior vena cava to sequester blood volume upstream from the adjustable component to reduce intracardiac filling pressures to provide therapy to treat the heart failure.

2. The method of claim 1 , wherein the adjustable component comprises an expandable member that is positioned within the superior vena cava.

3. The method of claim 2 , wherein the controller is programmed to estimate cardiac output of the patient's heart based at least in part on the sensor data and determine an optimal pressure gradient, the controller programmed to adjust the adjustable component to maintain the optimal pressure gradient.

4. The method of claim 3 , wherein the controller is programmed to generate a curve estimating the cardiac output relative to the sensor data and to identify a location on the curve corresponding to the optimal pressure gradient.

5. A system for treating a patient with heart failure, comprising:

a first elongate member comprising a proximal end and a distal end sized for introduction into a venous side of a patient's body;

at least one adjustable component carried on the first elongate member and configured to be positioned within a superior vena cava of the patient's body;

at least one sensor on the distal end of the first elongate member configured to provide sensor data corresponding to pressure within a right side of the patient's heart; and

a controller coupled to the at least one adjustable component and the at least one sensor, the controller programmed to selectively expand and collapse the at least one adjustable component intermittently within the superior vena cava based at least in part on the sensor data from the at least one sensor to occlude blood flow through the superior vena cava to generate a pressure gradient within the superior vena cava to sequester blood volume upstream from the adjustable component to reduce intracardiac filling pressures to provide therapy to treat the heart failure.

6. The system of claim 5 , wherein the adjustable component comprises an expandable member sized to be positioned within the superior vena cava.

7. The system of claim 6 , wherein the controller is programmed to estimate cardiac output of the patient's heart based at least in part on the sensor data and determine an optimal pressure gradient, the controller programmed to adjust the adjustable component to maintain the optimal pressure gradient.

8. The system of claim 7 , wherein the controller is programmed to generate a curve estimating the cardiac output relative to the sensor data and to identify a location on the curve corresponding to the optimal pressure gradient.

9. The method of claim 1 , wherein the at least one sensor is positioned within one of a right atrium, pulmonary artery, superior vena cava, inferior vena cava, right ventricle, and coronary sinus of the patient's heart.

10. The method of claim 1 , wherein the at least one sensor is positioned within the patient's superior vena cava.

11. The method of claim 1 , wherein the controller selectively expands and collapses the at least one adjustable component to occlude the blood flow through the superior vena cava while maintaining cardiac output of the heart.

12. The system of claim 5 , wherein the controller is configured to selectively expand and collapse the at least one adjustable component to occlude the blood flow through the superior vena cava while maintaining cardiac output of the heart.

13. The method of claim 1 , wherein the controller is programmed to adjust the adjustable component to generate a pressure gradient within the superior vena cava to sequester the blood volume upstream from the adjustable component without reducing cardiac output.

14. The method of claim 1 , wherein the controller is programmed to adjust the adjustable component to move extraneous and congesting fluid to vessels upstream from the adjustable component to sequester the blood volume.

15. The method of claim 1 , wherein the at least one sensor is positioned to provide sensor data corresponding to pressures upstream of the adjustable component.

16. A system for treating a patient with heart failure, comprising:

an elongate member comprising a proximal end and a distal end sized for introduction into a venous side of a patient's body;

at least one adjustable component carried on the elongate member and configured to be positioned within a superior vena cava of the patient's body;

at least one sensor on the distal end of the first elongate member configured to provide sensor data corresponding to pressure within a right side of the patient's heart; and

a controller coupled to the at least one adjustable component and the at least one sensor, the controller programmed to selectively expand and collapse the at least one adjustable component intermittently within the superior vena cava based at least in part on the sensor data from the at least one sensor to occlude blood flow through the superior vena cava to sequester blood volume upstream from the adjustable component to reduce intracardiac filling pressures to provide therapy to treat the heart failure.

17. The system of claim 16 , further comprising at least one additional sensor carried on the distal end of the elongate member and coupled to the controller for measuring cardiac output of the patient.

18. The system of claim 17 , wherein the at least one additional sensor comprises a plurality of electrodes configured to measure changes in electrical impedance that correlate with changes in blood volume.

19. The system of claim 18 , wherein the controller is coupled to the plurality of electrodes and configured to estimate cardiac output of the patient's heart by measuring the changes in electrical impedance from the plurality of electrodes.

20. The system of claim 19 , further comprising at least one catheter comprising the plurality of electrodes spaced apart along a distal end of the catheter capable of measuring electrical impedance.

21. The system of claim 17 , wherein the at least one additional sensor comprises a flow sensor capable of measuring the blood oxygen saturation.

22. The system of claim 16 , wherein the at least one sensor is configured to be located in one of the patient's pulmonary artery, right atrium, superior vena cava, inferior vena cava, right ventricle, left atrium, and coronary sinus.

23. The system of claim 17 , wherein the controller is configured to estimate left-sided filling pressures within the patient's heart by analyzing sensor data from at least two sensors.

24. The system of claim 16 , further comprising a second sensor configured to correspond to pressure proximal to the at least one adjustable component.

25. The system of claim 16 , wherein the elongate member comprises a first branch on the distal end carrying the at least one sensor, and a second branch on the distal end carrying the at least one adjustable component.

26. The system of claim 16 , wherein the at least one sensor is located on the distal end to provide sensor data corresponding to pressures upstream of the adjustable component.

27. A method for treating a patient with heart failure, comprising:

introducing a distal end of an elongate member into a right side of the patient's heart without introducing any devices into a left side of the patient's heart, the distal end carrying a balloon and at least one sensor;

manipulating the distal end of the elongate member to position the balloon on the distal end within the patient's superior vena cava, the at least one sensor providing sensor data for measuring pressures within a right side of the patient's heart; and

providing a controller operatively coupled to the balloon, the controller programmed to selectively expand and collapse the balloon within the superior vena cava to occlude blood flow within the superior vena cava to sequester blood volume upstream from the adjustable component to reduce intracardiac filling pressures to provide therapy to treat the heart failure.

28. The method of claim 27 , wherein the controller selectively expands and collapses the balloon to occlude the blood flow while maintaining cardiac output of the heart.

29. The method of claim 27 , wherein the controller selectively expands and collapses the balloon to occlude the blood flow while increasing cardiac output of the heart.

30. The method of claim 27 , wherein the controller is coupled to the at least one sensor, the controller programmed to selectively expand and collapse the balloon based at least in part on the sensor data from the at least one sensor to occlude the blood flow.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2024
From: KAISER, DANIEL WALTER; KAISER, CLAYTON ALLEN
To: CARDIOFLOW TECHNOLOGIES, LLC
Reel/Frame 066219/0816 →
Continuity (4)
Continuation 15882887 · Jan 29, 2018
Continuation 14597190 · Jan 14, 2015
Provisional Application 61927038 · Jan 14, 2014
Related Publication 20220001163A1 · Jan 6, 2022